Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 27 entries
Sorted by: Best Match Show Resources per page
EU-Wide Cross-Sectional Observational Study of Lipid-Modifying Therapy Use in Secondary and Primary Care: the DA VINCI study.

European journal of preventive cardiology

Ray KK, Molemans B, Schoonen WM, Giovas P, Bray S, Kiru G, Murphy J, Banach M, De Servi S, Gaita D, Gouni-Berthold I, Hovingh GK, Jozwiak JJ, Jukema JW, Kiss RG, Kownator S, Iversen HK, Maher V, Masana L, Parkhomenko A, Peeters A, Clifford P, Raslova K, Siostrzonek P, Romeo S, Tousoulis D, Vlachopoulos C, Vrablik M, Catapano AL, Poulter NR.
PMID: 33580789
Eur J Prev Cardiol. 2021 Sep 20;28(11):1279-1289. doi: 10.1093/eurjpc/zwaa047.

AIMS: To provide contemporary data on the implementation of European guideline recommendations for lipid-lowering therapies (LLTs) across different settings and populations and how this impacts low-density lipoprotein cholesterol (LDL-C) goal achievement.METHODS AND RESULTS: An 18 country, cross-sectional, observational study...

Cite
Ray KK, Molemans B, Schoonen WM, et al. EU-Wide Cross-Sectional Observational Study of Lipid-Modifying Therapy Use in Secondary and Primary Care: the DA VINCI study. Eur J Prev Cardiol. 2021;28(11):1279-1289doi: 10.1093/eurjpc/zwaa047.
Ray, K. K., Molemans, B., Schoonen, W. M., Giovas, P., Bray, S., Kiru, G., Murphy, J., Banach, M., De Servi, S., Gaita, D., Gouni-Berthold, I., Hovingh, G. K., Jozwiak, J. J., Jukema, J. W., Kiss, R. G., Kownator, S., Iversen, H. K., Maher, V., Masana, L., Parkhomenko, A., Peeters, A., Clifford, P., Raslova, K., Siostrzonek, P., Romeo, S., Tousoulis, D., Vlachopoulos, C., Vrablik, M., Catapano, A. L., Poulter, N. R. (2021). EU-Wide Cross-Sectional Observational Study of Lipid-Modifying Therapy Use in Secondary and Primary Care: the DA VINCI study. European journal of preventive cardiology, 28(11), 1279-1289. https://doi.org/10.1093/eurjpc/zwaa047
Ray, Kausik K, et al. "EU-Wide Cross-Sectional Observational Study of Lipid-Modifying Therapy Use in Secondary and Primary Care: the DA VINCI study." European journal of preventive cardiology vol. 28,11 (2021): 1279-1289. doi: https://doi.org/10.1093/eurjpc/zwaa047
Ray KK, Molemans B, Schoonen WM, Giovas P, Bray S, Kiru G, Murphy J, Banach M, De Servi S, Gaita D, Gouni-Berthold I, Hovingh GK, Jozwiak JJ, Jukema JW, Kiss RG, Kownator S, Iversen HK, Maher V, Masana L, Parkhomenko A, Peeters A, Clifford P, Raslova K, Siostrzonek P, Romeo S, Tousoulis D, Vlachopoulos C, Vrablik M, Catapano AL, Poulter NR. EU-Wide Cross-Sectional Observational Study of Lipid-Modifying Therapy Use in Secondary and Primary Care: the DA VINCI study. Eur J Prev Cardiol. 2021 Sep 20;28(11):1279-1289. doi: 10.1093/eurjpc/zwaa047. PMID: 33580789.
Copy Download .nbib Format: NLM
Residual SYNTAX Score and One-Year Outcome in Elderly Patients With Acute Coronary Syndrome.

CJC open

Morici N, Alicandro G, Ferri LA, Piatti L, Grosseto D, Sganzerla P, Tortorella G, Ferrario M, Crimi G, Bossi I, Tondi S, Petronio AS, Mariani M, Toso A, Ravera A, Corrada E, Cao D, Di Ascenzo L, La Vecchia C, De Servi S, Savonitto S.
PMID: 32695974
CJC Open. 2020 Mar 20;2(4):236-243. doi: 10.1016/j.cjco.2020.03.005. eCollection 2020 Jul.

BACKGROUND: The residual burden of coronary artery disease after percutaneous coronary intervention (PCI) has been associated with worse ischemic outcome. However, data are conflicting in elderly patients. The aim of our study was to verify the incremental value of...

Cite
Morici N, Alicandro G, Ferri LA, et al. Residual SYNTAX Score and One-Year Outcome in Elderly Patients With Acute Coronary Syndrome. CJC Open. 2020;2(4):236-243doi: 10.1016/j.cjco.2020.03.005.
Morici, N., Alicandro, G., Ferri, L. A., Piatti, L., Grosseto, D., Sganzerla, P., Tortorella, G., Ferrario, M., Crimi, G., Bossi, I., Tondi, S., Petronio, A. S., Mariani, M., Toso, A., Ravera, A., Corrada, E., Cao, D., Di Ascenzo, L., La Vecchia, C., De Servi, S., & Savonitto, S. (2020). Residual SYNTAX Score and One-Year Outcome in Elderly Patients With Acute Coronary Syndrome. CJC open, 2(4), 236-243. https://doi.org/10.1016/j.cjco.2020.03.005
Morici, Nuccia, et al. "Residual SYNTAX Score and One-Year Outcome in Elderly Patients With Acute Coronary Syndrome." CJC open vol. 2,4 (2020): 236-243. doi: https://doi.org/10.1016/j.cjco.2020.03.005
Morici N, Alicandro G, Ferri LA, Piatti L, Grosseto D, Sganzerla P, Tortorella G, Ferrario M, Crimi G, Bossi I, Tondi S, Petronio AS, Mariani M, Toso A, Ravera A, Corrada E, Cao D, Di Ascenzo L, La Vecchia C, De Servi S, Savonitto S. Residual SYNTAX Score and One-Year Outcome in Elderly Patients With Acute Coronary Syndrome. CJC Open. 2020 Mar 20;2(4):236-243. doi: 10.1016/j.cjco.2020.03.005. eCollection 2020 Jul. PMID: 32695974; PMCID: PMC7365822.
Copy Download .nbib Format: NLM
Optimal P2Y12 inhibition in older adults with acute coronary syndromes: A network meta-analysis of randomized controlled trials.

European heart journal. Cardiovascular pharmacotherapy

Montalto C, Morici N, Munafò AR, Mangieri A, Mandurino-Mirizzi A, D'Ascenzo F, Oreglia J, Latib A, Porto I, Colombo A, Savonitto S, De Servi S, Crimi G.
PMID: 32835355
Eur Heart J Cardiovasc Pharmacother. 2020 Aug 24; doi: 10.1093/ehjcvp/pvaa101. Epub 2020 Aug 24.

AIMS: Dual antiplatelet therapy (DAPT) with a P2Y12 inhibitor on top of aspirin is the cornerstone of therapy after acute coronary syndromes (ACS). Nonetheless, the safest and most efficacious P2Y12 for older patients who are both at high ischemic...

Cite
Montalto C, Morici N, Munafò AR, et al. Optimal P2Y12 inhibition in older adults with acute coronary syndromes: A network meta-analysis of randomized controlled trials. Eur Heart J Cardiovasc Pharmacother. 2020;doi: 10.1093/ehjcvp/pvaa101.
Montalto, C., Morici, N., Munafò, A. R., Mangieri, A., Mandurino-Mirizzi, A., D'Ascenzo, F., Oreglia, J., Latib, A., Porto, I., Colombo, A., Savonitto, S., De Servi, S., & Crimi, G. (2020). Optimal P2Y12 inhibition in older adults with acute coronary syndromes: A network meta-analysis of randomized controlled trials. European heart journal. Cardiovascular pharmacotherapy, . https://doi.org/10.1093/ehjcvp/pvaa101
Montalto, Claudio, et al. "Optimal P2Y12 inhibition in older adults with acute coronary syndromes: A network meta-analysis of randomized controlled trials." European heart journal. Cardiovascular pharmacotherapy vol. (2020). doi: https://doi.org/10.1093/ehjcvp/pvaa101
Montalto C, Morici N, Munafò AR, Mangieri A, Mandurino-Mirizzi A, D'Ascenzo F, Oreglia J, Latib A, Porto I, Colombo A, Savonitto S, De Servi S, Crimi G. Optimal P2Y12 inhibition in older adults with acute coronary syndromes: A network meta-analysis of randomized controlled trials. Eur Heart J Cardiovasc Pharmacother. 2020 Aug 24; doi: 10.1093/ehjcvp/pvaa101. Epub 2020 Aug 24. PMID: 32835355.
Copy Download .nbib Format: NLM
Acute Kidney Injury After Radial or Femoral Access for Invasive Acute Coronary Syndrome Management: AKI-MATRIX.

Journal of the American College of Cardiology

Andò G, Cortese B, Russo F, Rothenbühler M, Frigoli E, Gargiulo G, Briguori C, Vranckx P, Leonardi S, Guiducci V, Belloni F, Ferrari F, de la Torre Hernandez JM, Curello S, Liistro F, Perkan A, De Servi S, Casu G, Dellavalle A, Fischetti D, Micari A, Loi B, Mangiacapra F, Russo N, Tarantino F, Saia F, Heg D, Windecker S, Jüni P, Valgimigli M.
PMID: 28528767
J Am Coll Cardiol. 2017 May 11; doi: 10.1016/j.jacc.2017.02.070. Epub 2017 May 11.

BACKGROUND: It remains unclear whether radial access (RA), compared with femoral access (FA), mitigates the risk of acute kidney injury (AKI).OBJECTIVES: The authors assessed the incidence of AKI in patients with acute coronary syndrome (ACS) enrolled in the MATRIX-Access...

Cite
Andò G, Cortese B, Russo F, et al. Acute Kidney Injury After Radial or Femoral Access for Invasive Acute Coronary Syndrome Management: AKI-MATRIX. J Am Coll Cardiol. 2017;doi: 10.1016/j.jacc.2017.02.070.
Andò, G., Cortese, B., Russo, F., Rothenbühler, M., Frigoli, E., Gargiulo, G., Briguori, C., Vranckx, P., Leonardi, S., Guiducci, V., Belloni, F., Ferrari, F., de la Torre Hernandez, J. M., Curello, S., Liistro, F., Perkan, A., De Servi, S., Casu, G., Dellavalle, A., Fischetti, D., Micari, A., Loi, B., Mangiacapra, F., Russo, N., Tarantino, F., Saia, F., Heg, D., Windecker, S., Jüni, P., Valgimigli, M. (2017). Acute Kidney Injury After Radial or Femoral Access for Invasive Acute Coronary Syndrome Management: AKI-MATRIX. Journal of the American College of Cardiology, . https://doi.org/10.1016/j.jacc.2017.02.070
Andò, Giuseppe, et al. "Acute Kidney Injury After Radial or Femoral Access for Invasive Acute Coronary Syndrome Management: AKI-MATRIX." Journal of the American College of Cardiology vol. (2017). doi: https://doi.org/10.1016/j.jacc.2017.02.070
Andò G, Cortese B, Russo F, Rothenbühler M, Frigoli E, Gargiulo G, Briguori C, Vranckx P, Leonardi S, Guiducci V, Belloni F, Ferrari F, de la Torre Hernandez JM, Curello S, Liistro F, Perkan A, De Servi S, Casu G, Dellavalle A, Fischetti D, Micari A, Loi B, Mangiacapra F, Russo N, Tarantino F, Saia F, Heg D, Windecker S, Jüni P, Valgimigli M. Acute Kidney Injury After Radial or Femoral Access for Invasive Acute Coronary Syndrome Management: AKI-MATRIX. J Am Coll Cardiol. 2017 May 11; doi: 10.1016/j.jacc.2017.02.070. Epub 2017 May 11. PMID: 28528767.
Copy Download .nbib Format: NLM
[Bilateral resection in the surgical treatment of pulmonary tuberculosis; results in 12 consecutive cases].

Revista brasileira de tuberculose e doencas toracicas

GUERTZENSTEIN E, DE SIERVI M, BURLA A, LACOMBE A.
PMID: 13624202
Rev Bras Tuberc Doencas Torac. 1958 Dec;26(200):1637-48.

No abstract available.

Cite
GUERTZENSTEIN E, DE SIERVI M, BURLA A, et al. As ressecçōes bilaterais no tratamento cirúrgico da tuberculose pulmonar: resultados em 12 casos consecutivos. [Bilateral resection in the surgical treatment of pulmonary tuberculosis; results in 12 consecutive cases]. Rev Bras Tuberc Doencas Torac. 1958;26(200):1637-48
GUERTZENSTEIN, E., DE SIERVI, M., BURLA, A., & LACOMBE, A. (1958). As ressecçōes bilaterais no tratamento cirúrgico da tuberculose pulmonar: resultados em 12 casos consecutivos. [Bilateral resection in the surgical treatment of pulmonary tuberculosis; results in 12 consecutive cases]. Revista brasileira de tuberculose e doencas toracicas, 26(200), 1637-48.
GUERTZENSTEIN, E, et al. "As ressecçōes bilaterais no tratamento cirúrgico da tuberculose pulmonar: resultados em 12 casos consecutivos." [Bilateral resection in the surgical treatment of pulmonary tuberculosis; results in 12 consecutive cases]. Revista brasileira de tuberculose e doencas toracicas vol. 26,200 (1958): 1637-48.
GUERTZENSTEIN E, DE SIERVI M, BURLA A, LACOMBE A. As ressecçōes bilaterais no tratamento cirúrgico da tuberculose pulmonar: resultados em 12 casos consecutivos. [Bilateral resection in the surgical treatment of pulmonary tuberculosis; results in 12 consecutive cases]. Rev Bras Tuberc Doencas Torac. 1958 Dec;26(200):1637-48. Undetermined. PMID: 13624202.
Copy Download .nbib Format: NLM
Takotsubo syndrome and electrical storm following electrical cardioversion of atrial fibrillation: cause, consequence or both?.

Journal of cardiovascular medicine (Hagerstown, Md.)

Landi A, De Servi S.
PMID: 33351534
J Cardiovasc Med (Hagerstown). 2021 Feb 01;22(2):139-142. doi: 10.2459/JCM.0000000000001021.

No abstract available.

Cite
Landi A, De Servi S. Takotsubo syndrome and electrical storm following electrical cardioversion of atrial fibrillation: cause, consequence or both?. J Cardiovasc Med (Hagerstown). 2021;22(2):139-142doi: 10.2459/JCM.0000000000001021.
Landi, A., & De Servi, S. (2021). Takotsubo syndrome and electrical storm following electrical cardioversion of atrial fibrillation: cause, consequence or both?. Journal of cardiovascular medicine (Hagerstown, Md.), 22(2), 139-142. https://doi.org/10.2459/JCM.0000000000001021
Landi, Antonio, and De Servi, Stefano. "Takotsubo syndrome and electrical storm following electrical cardioversion of atrial fibrillation: cause, consequence or both?." Journal of cardiovascular medicine (Hagerstown, Md.) vol. 22,2 (2021): 139-142. doi: https://doi.org/10.2459/JCM.0000000000001021
Landi A, De Servi S. Takotsubo syndrome and electrical storm following electrical cardioversion of atrial fibrillation: cause, consequence or both?. J Cardiovasc Med (Hagerstown). 2021 Feb 01;22(2):139-142. doi: 10.2459/JCM.0000000000001021. PMID: 33351534.
Copy Download .nbib Format: NLM
Validation and Additive Predictive Value of the Academic Research Consortium-High Bleeding Risk Criteria in Older Adults.

Thrombosis and haemostasis

Montalto C, Crimi G, Morici N, Palmerini T, Valgimigli M, Savonitto S, De Servi S.
PMID: 33352592
Thromb Haemost. 2021 Sep;121(9):1255-1257. doi: 10.1055/a-1342-3750. Epub 2020 Dec 22.

No abstract available.

Cite
Montalto C, Crimi G, Morici N, et al. Validation and Additive Predictive Value of the Academic Research Consortium-High Bleeding Risk Criteria in Older Adults. Thromb Haemost. 2020;121(9):1255-1257doi: 10.1055/a-1342-3750.
Montalto, C., Crimi, G., Morici, N., Palmerini, T., Valgimigli, M., Savonitto, S., & De Servi, S. (2021). Validation and Additive Predictive Value of the Academic Research Consortium-High Bleeding Risk Criteria in Older Adults. Thrombosis and haemostasis, 121(9), 1255-1257. https://doi.org/10.1055/a-1342-3750
Montalto, Claudio, et al. "Validation and Additive Predictive Value of the Academic Research Consortium-High Bleeding Risk Criteria in Older Adults." Thrombosis and haemostasis vol. 121,9 (2021): 1255-1257. doi: https://doi.org/10.1055/a-1342-3750
Montalto C, Crimi G, Morici N, Palmerini T, Valgimigli M, Savonitto S, De Servi S. Validation and Additive Predictive Value of the Academic Research Consortium-High Bleeding Risk Criteria in Older Adults. Thromb Haemost. 2021 Sep;121(9):1255-1257. doi: 10.1055/a-1342-3750. Epub 2020 Dec 22. PMID: 33352592.
Copy Download .nbib Format: NLM
Impact of renal dysfunction and acute kidney injury on outcome in elderly patients with acute coronary syndrome undergoing percutaneous coronary intervention.

European heart journal. Acute cardiovascular care

De Rosa R, Morici N, De Servi S, De Luca G, Galasso G, Piscione F, Ferri LA, Piatti L, Grosseto D, Tortorella G, Franco N, Lenatti L, Misuraca L, Leuzzi C, Verdoia M, Sganzerla P, Cacucci M, Ferrario M, Murena E, Sibilio G, Toso A, Savonitto S.
PMID: 32374175
Eur Heart J Acute Cardiovasc Care. 2020 May 06;2048872620920475. doi: 10.1177/2048872620920475. Epub 2020 May 06.

BACKGROUND: Chronic kidney disease is common in patients admitted with acute coronary syndrome and its prevalence dramatically increases with age. Understanding the determinants of adverse outcomes in this extremely high-risk population may be useful for the development of specific...

Cite
De Rosa R, Morici N, De Servi S, et al. Impact of renal dysfunction and acute kidney injury on outcome in elderly patients with acute coronary syndrome undergoing percutaneous coronary intervention. Eur Heart J Acute Cardiovasc Care. 2020;2048872620920475doi: 10.1177/2048872620920475.
De Rosa, R., Morici, N., De Servi, S., De Luca, G., Galasso, G., Piscione, F., Ferri, L. A., Piatti, L., Grosseto, D., Tortorella, G., Franco, N., Lenatti, L., Misuraca, L., Leuzzi, C., Verdoia, M., Sganzerla, P., Cacucci, M., Ferrario, M., Murena, E., Sibilio, G., Toso, A., & Savonitto, S. (2020). Impact of renal dysfunction and acute kidney injury on outcome in elderly patients with acute coronary syndrome undergoing percutaneous coronary intervention. European heart journal. Acute cardiovascular care, 2048872620920475. https://doi.org/10.1177/2048872620920475
De Rosa, Roberta, et al. "Impact of renal dysfunction and acute kidney injury on outcome in elderly patients with acute coronary syndrome undergoing percutaneous coronary intervention." European heart journal. Acute cardiovascular care vol. (2020): 2048872620920475. doi: https://doi.org/10.1177/2048872620920475
De Rosa R, Morici N, De Servi S, De Luca G, Galasso G, Piscione F, Ferri LA, Piatti L, Grosseto D, Tortorella G, Franco N, Lenatti L, Misuraca L, Leuzzi C, Verdoia M, Sganzerla P, Cacucci M, Ferrario M, Murena E, Sibilio G, Toso A, Savonitto S. Impact of renal dysfunction and acute kidney injury on outcome in elderly patients with acute coronary syndrome undergoing percutaneous coronary intervention. Eur Heart J Acute Cardiovasc Care. 2020 May 06;2048872620920475. doi: 10.1177/2048872620920475. Epub 2020 May 06. PMID: 32374175.
Copy Download .nbib Format: NLM
Soluble CD40 ligand and outcome in patients with coronary artery disease undergoing percutaneous coronary intervention.

Clinical chemistry and laboratory medicine

Angeli F, Verdecchia P, Savonitto S, Cavallini S, Santucci A, Coiro S, Sclafani R, Riccini C, De Servi S, Cavallini C.
PMID: 34714987
Clin Chem Lab Med. 2021 Nov 01;60(1):118-126. doi: 10.1515/cclm-2021-0817. Print 2022 Jan 26.

OBJECTIVES: CD40 ligand (CD40L), a transmembrane glycoprotein belonging to the tumor necrosis factor family and expressed by a variety of cells, is involved in the basic mechanisms of inflammation, atherosclerosis and thrombosis. Some studies suggest that the soluble form...

Cite
Angeli F, Verdecchia P, Savonitto S, et al. Soluble CD40 ligand and outcome in patients with coronary artery disease undergoing percutaneous coronary intervention. Clin Chem Lab Med. 2021;60(1):118-126doi: 10.1515/cclm-2021-0817.
Angeli, F., Verdecchia, P., Savonitto, S., Cavallini, S., Santucci, A., Coiro, S., Sclafani, R., Riccini, C., De Servi, S., & Cavallini, C. (2022). Soluble CD40 ligand and outcome in patients with coronary artery disease undergoing percutaneous coronary intervention. Clinical chemistry and laboratory medicine, 60(1), 118-126. https://doi.org/10.1515/cclm-2021-0817
Angeli, Fabio, et al. "Soluble CD40 ligand and outcome in patients with coronary artery disease undergoing percutaneous coronary intervention." Clinical chemistry and laboratory medicine vol. 60,1 (2022): 118-126. doi: https://doi.org/10.1515/cclm-2021-0817
Angeli F, Verdecchia P, Savonitto S, Cavallini S, Santucci A, Coiro S, Sclafani R, Riccini C, De Servi S, Cavallini C. Soluble CD40 ligand and outcome in patients with coronary artery disease undergoing percutaneous coronary intervention. Clin Chem Lab Med. 2021 Nov 01;60(1):118-126. doi: 10.1515/cclm-2021-0817. Print 2022 Jan 26. PMID: 34714987.
Copy Download .nbib Format: NLM
Impact of renal dysfunction and acute kidney injury on outcome in elderly patients with acute coronary syndrome undergoing percutaneous coronary intervention.

European heart journal. Acute cardiovascular care

De Rosa R, Morici N, De Servi S, De Luca G, Galasso G, Piscione F, Ferri LA, Piatti L, Grosseto D, Tortorella G, Franco N, Lenatti L, Misuraca L, Leuzzi C, Verdoia M, Sganzerla P, Cacucci M, Ferrario M, Murena E, Sibilio G, Toso A, Savonitto S.
PMID: 33609123
Eur Heart J Acute Cardiovasc Care. 2020 May 06; doi: 10.1177/2048872620920475. Epub 2020 May 06.

BACKGROUND: Chronic kidney disease is common in patients admitted with acute coronary syndrome and its prevalence dramatically increases with age. Understanding the determinants of adverse outcomes in this extremely high-risk population may be useful for the development of specific...

Cite
De Rosa R, Morici N, De Servi S, et al. Impact of renal dysfunction and acute kidney injury on outcome in elderly patients with acute coronary syndrome undergoing percutaneous coronary intervention. Eur Heart J Acute Cardiovasc Care. 2020;doi: 10.1177/2048872620920475.
De Rosa, R., Morici, N., De Servi, S., De Luca, G., Galasso, G., Piscione, F., Ferri, L. A., Piatti, L., Grosseto, D., Tortorella, G., Franco, N., Lenatti, L., Misuraca, L., Leuzzi, C., Verdoia, M., Sganzerla, P., Cacucci, M., Ferrario, M., Murena, E., Sibilio, G., Toso, A., & Savonitto, S. (2020). Impact of renal dysfunction and acute kidney injury on outcome in elderly patients with acute coronary syndrome undergoing percutaneous coronary intervention. European heart journal. Acute cardiovascular care, . https://doi.org/10.1177/2048872620920475
De Rosa, Roberta, et al. "Impact of renal dysfunction and acute kidney injury on outcome in elderly patients with acute coronary syndrome undergoing percutaneous coronary intervention." European heart journal. Acute cardiovascular care vol. (2020). doi: https://doi.org/10.1177/2048872620920475
De Rosa R, Morici N, De Servi S, De Luca G, Galasso G, Piscione F, Ferri LA, Piatti L, Grosseto D, Tortorella G, Franco N, Lenatti L, Misuraca L, Leuzzi C, Verdoia M, Sganzerla P, Cacucci M, Ferrario M, Murena E, Sibilio G, Toso A, Savonitto S. Impact of renal dysfunction and acute kidney injury on outcome in elderly patients with acute coronary syndrome undergoing percutaneous coronary intervention. Eur Heart J Acute Cardiovasc Care. 2020 May 06; doi: 10.1177/2048872620920475. Epub 2020 May 06. PMID: 33609123.
Copy Download .nbib Format: NLM
Optimal P2Y12 inhibition in older adults with acute coronary syndromes: a network meta-analysis of randomized controlled trials.

European heart journal. Cardiovascular pharmacotherapy

Montalto C, Morici N, Munafò AR, Mangieri A, Mandurino-Mirizzi A, D'Ascenzo F, Oreglia J, Latib A, Porto I, Colombo A, Savonitto S, De Servi S, Crimi G.
PMID: 32835355
Eur Heart J Cardiovasc Pharmacother. 2022 Jan 05;8(1):20-27. doi: 10.1093/ehjcvp/pvaa101.

AIMS: Dual antiplatelet therapy (DAPT) with a P2Y12 inhibitor on top of aspirin is the cornerstone of therapy after acute coronary syndromes (ACS). Nonetheless, the safest and most efficacious P2Y12 for older patients who are both at high ischaemic...

Cite
Montalto C, Morici N, Munafò AR, et al. Optimal P2Y12 inhibition in older adults with acute coronary syndromes: a network meta-analysis of randomized controlled trials. Eur Heart J Cardiovasc Pharmacother. 2022;8(1):20-27doi: 10.1093/ehjcvp/pvaa101.
Montalto, C., Morici, N., Munafò, A. R., Mangieri, A., Mandurino-Mirizzi, A., D'Ascenzo, F., Oreglia, J., Latib, A., Porto, I., Colombo, A., Savonitto, S., De Servi, S., & Crimi, G. (2022). Optimal P2Y12 inhibition in older adults with acute coronary syndromes: a network meta-analysis of randomized controlled trials. European heart journal. Cardiovascular pharmacotherapy, 8(1), 20-27. https://doi.org/10.1093/ehjcvp/pvaa101
Montalto, Claudio, et al. "Optimal P2Y12 inhibition in older adults with acute coronary syndromes: a network meta-analysis of randomized controlled trials." European heart journal. Cardiovascular pharmacotherapy vol. 8,1 (2022): 20-27. doi: https://doi.org/10.1093/ehjcvp/pvaa101
Montalto C, Morici N, Munafò AR, Mangieri A, Mandurino-Mirizzi A, D'Ascenzo F, Oreglia J, Latib A, Porto I, Colombo A, Savonitto S, De Servi S, Crimi G. Optimal P2Y12 inhibition in older adults with acute coronary syndromes: a network meta-analysis of randomized controlled trials. Eur Heart J Cardiovasc Pharmacother. 2022 Jan 05;8(1):20-27. doi: 10.1093/ehjcvp/pvaa101. PMID: 32835355.
Copy Download .nbib Format: NLM
[No title available]

Giornale italiano di cardiologia (2006)

De Servi S.
PMID: 34570122
G Ital Cardiol (Rome). 2021 Oct;22(10):869. doi: 10.1714/3666.36519.

No abstract available.

Cite
De Servi S. Manuale di Terapia Cardiovascolare – Quinta Edizione – a cura di Stefano Savonitto ed Enrico Ammirati. . G Ital Cardiol (Rome). 2021;22(10):869doi: 10.1714/3666.36519.
De Servi, S. (2021). Manuale di Terapia Cardiovascolare – Quinta Edizione – a cura di Stefano Savonitto ed Enrico Ammirati. . Giornale italiano di cardiologia (2006), 22(10), 869. https://doi.org/10.1714/3666.36519
De Servi, Stefano. "Manuale di Terapia Cardiovascolare – Quinta Edizione – a cura di Stefano Savonitto ed Enrico Ammirati." . Giornale italiano di cardiologia (2006) vol. 22,10 (2021): 869. doi: https://doi.org/10.1714/3666.36519
De Servi S. Manuale di Terapia Cardiovascolare – Quinta Edizione – a cura di Stefano Savonitto ed Enrico Ammirati. . G Ital Cardiol (Rome). 2021 Oct;22(10):869. doi: 10.1714/3666.36519. Italian. PMID: 34570122.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 27 entries